Ocugen Inc.

11/20/2024 | Press release | Distributed by Public on 11/20/2024 07:15

Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate OCU410ST for Treatment of ABCA4-Associated[...]